Clinical Characterization and Underlying Genetic Findings in Brazilian Patients with Syndromic Microcephaly Associated with Neurodevelopmental Disorders

Giovanna Cantini Tolezano,Giovanna Civitate Bastos,Silvia Souza da Costa,Marília de Oliveira Scliar,Carolina Fischinger Moura de Souza,Hélio Van Der Linden Jr,Walter Luiz Magalhães Fernandes,Paulo Alberto Otto,Angela M. Vianna-Morgante,Luciana Amaral Haddad,Rachel Sayuri Honjo,Guilherme Lopes Yamamoto,Chong Ae Kim,Carla Rosenberg,Alexander Augusto de Lima Jorge,Débora Romeo Bertola,Ana Cristina Victorino Krepischi
DOI: https://doi.org/10.1007/s12035-023-03894-8
IF: 5.682
2024-01-07
Molecular Neurobiology
Abstract:Microcephaly is characterized by an occipitofrontal circumference at least two standard deviations below the mean for age and sex. Neurodevelopmental disorders (NDD) are commonly associated with microcephaly, due to perturbations in brain development and functioning. Given the extensive genetic heterogeneity of microcephaly, managing patients is hindered by the broad spectrum of diagnostic possibilities that exist before conducting molecular testing. We investigated the genetic basis of syndromic microcephaly accompanied by NDD in a Brazilian cohort of 45 individuals and characterized associated clinical features, as well as evaluated the effectiveness of whole-exome sequencing (WES) as a diagnostic tool for this condition. Patients previously negative for pathogenic copy number variants underwent WES, which was performed using a trio approach for isolated index cases ( n = 31), only the index in isolated cases with parental consanguinity ( n = 8) or affected siblings in familial cases ( n = 3). Pathogenic/likely pathogenic variants were identified in 19 families (18 genes) with a diagnostic yield of approximately 45%. Nearly 86% of the individuals had global developmental delay/intellectual disability and 51% presented with behavioral disturbances. Additional frequent clinical features included facial dysmorphisms (80%), brain malformations (67%), musculoskeletal (71%) or cardiovascular (47%) defects, and short stature (54%). Our findings unraveled the underlying genetic basis of microcephaly in half of the patients, demonstrating a high diagnostic yield of WES for microcephaly and reinforcing its genetic heterogeneity. We expanded the phenotypic spectrum associated with the condition and identified a potentially novel gene ( CCDC17 ) for congenital microcephaly.
neurosciences
What problem does this paper attempt to address?